Home / Publications / Pain Research Forum / Papers of the Week / Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report.
Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report.
Davis C, Tipton T, Sabir S, Aitken C, Bennett S, Becker S, Evans T, Fehling S K, Gunson R, Hall Y, Jackson C, Johanssen I, Kieny M P, McMenamin J, Spence E, Strecker T, Sykes C, Templeton K, Thorburn F, Peters E, et al.
In October 2015, 65 people came into direct contact with a healthcare worker presenting with a late reactivation of Ebola virus disease (EVD) in the UK. Vaccination was offered to 45 individuals with an initial assessment of high exposure risk.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
